Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
XFOR
XFOR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XFOR News
X4 Pharmaceuticals Receives Positive EMA Opinion for Mavorixafor
Feb 27 2026
NASDAQ.COM
X4 Pharmaceuticals Receives Positive Opinion for WHIM Syndrome Therapy in EU
Feb 27 2026
Newsfilter
Sanofi Acquires Dynavax for $15.50 per Share, Totaling $2.2 Billion
Dec 24 2025
Benzinga
Examining X4 Pharmaceuticals' Story Following Leadership Transitions and Recent Funding
Nov 24 2025
Yahoo Finance
Insider Buying Update for Tuesday, October 28: CRMD and XFOR
Oct 28 2025
NASDAQ.COM
Healthcare Rally: Pulmonx, UHS, and X4 Experience After-Hours Gains Following Strategic Announcements
Oct 28 2025
NASDAQ.COM
X4 Pharmaceuticals Sees 5% Decline After Pricing $135M Equity Offering
Oct 24 2025
SeekingAlpha
X4 Pharmaceuticals (XFOR) Receives Strong Buy Upgrade: Implications for the Stock
Oct 22 2025
NASDAQ.COM
Altimmune Names Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Lead Clinical Development of Pemvidutide
Sep 28 2025
Globenewswire
X4 Pharmaceuticals Implements Restructuring Following CMO Resignation; Aims for $13 Million Savings with 50% Workforce Reduction
Sep 17 2025
NASDAQ.COM
Sitryx Names Adam Mostafa as CFO
Sep 08 2025
Newsfilter
3 Penny Stocks to Watch Now, 8/14/25
Aug 14 2025
TipRanks
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
Aug 13 2025
Newsfilter
X4 Pharma Secures $60 Mln PIPE Financing; CEO, CFO Resign; Replacements Named
Aug 12 2025
NASDAQ.COM
X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership
Aug 12 2025
Newsfilter
X4 Pharmaceuticals secures $60M PIPE financing
Aug 12 2025
SeekingAlpha
Show More News
